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.2013.01.Abstract Introduction: Systemic administration of lidocaine signiﬁcantly decreased propofol
requirements when compared to patients receiving placebo. Several studies conducted on animals
have proved that systemic local anesthetics reduced minimum alveolar concentration (MAC) of
inhalational anesthetics. The aim of this investigation is to study the effect of intravenous admin-
istration of lidocaine on the minimum alveolar concentration of sevoﬂurane required to keep
BIS between 40 and 60 during maintenance of anesthesia in humans.
Methods: Twenty-eight ASA I–II adults planned to undergo laparoscopic procedures expected to
last <2 h under general anesthesia were randomly assigned to 2 groups. After standardized induc-
tion of general anesthesia, patients were given IV lidocaine bolus (1.5 mg kg1) followed by
2 mg kg1 h1 infusion (group L, n= 14) or equal volumes of saline (group C, n= 14). Primary
outcome of the study was end-tidal sevoﬂurane at bispectral index (BIS) values of 40–60. Secondary
outcomes included doses of opioids, BIS values, and extubation time.
Results: The median doses of intraoperative fentanyl (range) in group C were similar to group L
(P= 0.08). There were no signiﬁcant differences between the 2 groups regarding BIS at any time
point. End-tidal sevoﬂurane concentrations were signiﬁcantly higher in group C than in group L
at all intraoperative time points (P< 0.05). Extubation time was longer in group L than in group
C (P= 0.04).ing Fahd Military Medical
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yahoo.com (A.M. Omar),
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236 A.M. Omar, O.H. AboushanabConclusion: In conclusion, intravenous lidocaine administration, during maintenance of general
anesthesia, can decrease BIS-guided sevoﬂurane requirements.
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Several studies were conducted in humans to evaluate the ef-
fect of systemic lidocaine on anesthetic and opioid require-
ments. Systemic administration of local anesthetics
signiﬁcantly decreased propofol requirements when compared
to patients in control group [1,2]. Perioperative requirements
of opioids were reduced by 40% in patients who received intra-
venous lidocaine infusion during maintenance of anesthesia
than those who received saline [3].
Several studies conducted on animals proved that systemic
local anesthetics reduced minimum alveolar concentration
(MAC) of inhalational anesthetics and analgesic requirements
[4,5]. The mechanism of MAC reduction by lidocaine was not
completely clariﬁed. Sedative and analgesic effects of lidocaine
might have a role.
We hypothesized that lidocaine may have a similar effect on
MAC in humans. The aim of this investigation is to study the
effect of intravenous administration of lidocaine on the mini-
mum alveolar concentration of sevoﬂurane required to keep
BIS between 40 and 60 during maintenance of anesthesia in
humans.
2. Methods
This study was conducted in King Fahd Military Hospital,
Dhahran, KSA from February 2012 to August 2012 after
obtaining approval by its ethical committee. A written consent
was obtained from a number of adult ASA I and II patients
undergoing elective laparoscopic surgeries expected to last less
than 2 h. Exclusion criteria included patients with BMI less than
20ormore than 35. Patientswith history of reaction to lidocaine,
patients with history of seizures or using sedatives, hypnotics or
any other drugs that affect BIS, were also excluded.
Standard monitors were used including ECG, non-invasive
arterial pressure, and pulse oximetry. Peripheral nerve stimula-
tor was used to guide administration of muscle relaxant and its
reversal at the end of surgery. BIS (Aspect Medical Systems
Inc. BIS Vista, USA) was also used to assess the depth of
anesthesia.
After 6 h of fasting, anesthesia was induced using fentanyl
2 mcg kg1 i.v. followed after 3 min by propofol 1.5–
2.5 mg kg1 iv. When BIS reached less than 50, atracurium
0.5 mg/kg iv was administered to allow tracheal intubation,
which was performed when there was no response to train of
four (TOF) stimulation. The lungs were ventilated with a tidal
volume of 7–8 ml kg1 and an oxygen fraction of 0.4 in air.
The respiratory rate was adjusted to maintain an end tidal
CO2 between 30 and 35 mm Hg.
Patients were randomly allocated into 2 groups using com-
puter-produced randomization tables. Patients in group L re-
ceived 1.5 mg kg1 bolus of 1% lidocaine i.v. followed by
2 mg kg1 h1 infusion while those in group C received equal
volumes of saline. The study medications were prepared by ahospital pharmacist who was not involved in the study. Each
drug syringe was given a code which remained blinded until
statistical analysis has been completed. The anesthesiologist
who was blinded to group allocation injected the bolus over
a period of 1 min, and then started the infusion 5 min after tra-
cheal intubation.
During maintenance of anesthesia, sevoﬂurane concentra-
tion was adjusted to keep BIS between 40 and 60. Sevoﬂurane
was increased or decreased by 0.5% if BIS goes outside this
range. Boluses of fentanyl (20–50 lg i.v.) were injected to
maintain arterial pressure within 20% of the baseline mean
arterial pressure. BIS values and end-tidal sevoﬂurane concen-
tration were also recorded every 10 min.
After the end of surgery, sevoﬂurane and the study infusions
were discontinued. Neuromuscular block was reversed by atro-
pine (10–15 mcg kg1) and neostigmine (40–50 mcg kg1) and
the patients were extubated awake.
The primary outcome of the study was the end-tidal sevoﬂu-
rane at BIS 40–60. Based on a previous article [6], the mean
(±SD) minimum alveolar concentrations of sevoﬂurane in
adults is 1.9 (0.24)%. We assumed that a 20% difference in
end-tidal sevoﬂurane at BIS 40–60 between the groups would
be clinically signiﬁcant. A sample size was calculated to be 12
at an alpha error of 0.01 and beta error of 0.1. Fourteen cases
were enrolled in each group to compensate for dropouts. Sec-
ondary outcomes included doses of opioids used intraopera-
tively, BIS values recorded every 5 min, cumulative dose of
lidocaine, extubation time (deﬁned as time from sevoﬂurane dis-
continuation to tracheal extubation), and intraoperative recall.
Statistical analyses were performed using the SPSS for Win-
dows, version 15 (SPSS Inc., Chicago, IL). Data were ﬁrst
tested for normality by Klomogorov–Smirnov test. Normally
distributed continuous data were analyzed by using student
t-test. Non-normally distributed continuous and ordinal data
were analyzed using Mann–Whitey U test. Categorical data
was analyzed by chi square or Fisher’s exact test as appropri-
ate. The results are presented as mean ± SD, median (range),
or number of patients as appropriate. A P value < 0.05 was
considered statistically signiﬁcant.3. Results
Forty-three patients were found eligible for the study. Five pa-
tients refused participation and 10 patients met our exclusion
criteria. Twenty-eight patients were randomized into 2 groups:
Control (C) group (n= 14) and Lidocaine (L) group P
(n= 14). No patient was excluded from the study.
The 2 study groups were found to be similar regarding to
demographic and surgical data except for anesthesia time
which was longer in group L (Table 1). The median doses of
intraoperative fentanyl (range) in group C [200(200–300)] were
similar to group L [150(120–300)] (P= 0.08). The mean
(±SD) cumulative dose of lidocaine given to patients in group
L was 301(29) mg.






Age (yr) 39(11) 37(10) NS
Sex (M/F) 6/8 7/7 NS
BMI (kg m2) 26.7(2.2) 24.5(1.8) NS
ASA (I/II) 5/9 6/8 NS
Surgery
Cholecystectomy 5 6 NS
Hernial repair 4 4 NS
Appendectomy 5 4 NS
Duration of surgery (min) 51(18) 47(20) NS
Duration of anesthesia (min) 60(17) 77(23) 0.04
Data are mean (±SD) or number. Group C: control; group L:
lidocaine; BMI: body mass index; NS: non-signiﬁcant.
Figure 1 Mean (±SD) intraoperative bispectral index (BIS).
Group C: control; group L: lidocaine. P > 0.05 at all time points.
Figure 2 Mean (±SD) end-tidal sevoﬂurane (ET-sevo) concen-
trations. Group C: control; group L: lidocaine \P< 0.05.
Figure 3 Mean (±SD) heart rate. Group C: control; group L:
lidocaine; bpm: beat per minute. P> 0.05 at all time points.
Figure 4 Mean (±SD) mean blood pressure (MBP). Group C:
control; group L: lidocaine. P> 0.05 at all time points.
Effect of intravenous lidocaine infusion on sevoﬂurane requirements as monitored by bispectral index 237There were no signiﬁcant differences between the 2 groups
regarding BIS at any time point (ﬁg 1). End-tidal sevoﬂurane
concentrations were signiﬁcantly higher in group C than in
group L at all intraoperative time points (ﬁg 2). No signiﬁcant
differences were detected between the 2 groups regarding the
hemodynamic parameters (ﬁg 3 and 4).
No patient in the 2 groups reported intraoperative aware-
ness when asked about it the day following surgery.
4. Discussion
This study shows that i.v. lidocaine at a dose of 1.5 mg kg1
bolus followed by 2 mg kg h1, reduces sevoﬂurane require-
ment while maintaining BIS score between 40 and 60, duringmaintenance of anesthesia in patients undergoing laparoscopic
surgeries.
Systemic lidocaine infusion has been used in several studies
to evaluate its beneﬁts on the outcome of anesthesia. Having
inﬂammation-modulatory properties [7], it signiﬁcantly re-
duced pain and allowed more rapid discharge [8]. In a meta-
analysis of 8 randomized, controlled, clinical trials, patients
who underwent abdominal surgeries while receiving continu-
ous perioperative i.v. lidocaine, showed less duration of post-
operative ileus, less pain, nausea, and vomiting and shorter
hospital stay [9]. McKay et al. proved that patients who re-
ceived perioperative lidocaine infusion, required less opioid
and had shorter length of PACU stay [3]. Groudine et al. also
observed that i.v. lidocaine infusion was associated with signif-
icant decrease in postoperative pain and duration of hospital-
ization [10]. Despite the higher doses of fentanyl used in the
control group compared to the lidocaine group in our study,
they did not reach a statistical signiﬁcance. The study was per-
haps not powered enough to detect this difference (fentanyl
dose was not our primary outcome). In one animal study pub-
lished in 2012 by Columbano et al., it was found that there was
no reduction in sevoﬂurane requirements when fentanyl was
used contrary to buprenorphine. They concluded that the type
of opioid used is the factor that may affect sevoﬂurane require-
ments [11].
Systemic lidocaine has proved to reduce MAC in animals.
Wilson et al. observed in a study that lidocaine with or without
ketamine signiﬁcantly reduced the MAC of sevoﬂurane in dogs
[12]. Matsubara et al. also found that intravenous lidocaine
decreased MAC of sevoﬂurane in anesthetized dogs without
affecting blood pressure or heart rate [13]. Pypendop and Ilkiw
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reduced the MAC of isoﬂurane in cats [14].
The effect of i.v. lidocaine on MAC was suggested to be due
to its action at the spinal level by decreasing the motor response
[15]. However, it was observed that intravenous lidocaine
infusion reduced bispectral index-guided propofol requirement
during TIVA [16,17]. These studies supported that the mecha-
nism by which intravenous lidocaine decreased anesthetic
requirements was due to its inhibitory effect at the central
nervous system. In a case report, lidocaine was inadvertently
administered at a dose of 100 mg per min for 7–8 min and
BIS read zero [18]. This incidence supported that brain activity
was decreased by systemic lidocaine administration.
The only study conducted on humans to explore the effect
of lidocaine on MAC was done by Hodgson and Liu [19]. They
found that epidural lidocaine reduced the end-tidal sevoﬂurane
required for BIS less than 50 compared with sole general anes-
thesia by 34% explaining this by rostral migration of lidocaine
to the brain cerebrospinal ﬂuid. Moreover, they did not ﬁnd a
MAC-reducing effect of systemic lidocaine when given in doses
that reach plasma levels comparable to epidural lidocaine
(about 2 mcg ml1). There are some differences between their
study and ours that can explain the different ﬁndings. The
doses of systemic lidocaine used are different. We used 1.5
mg kg1 as a bolus dose then 2 mg kg1 h1 as an infusion
while they used 1 mg kg1 as a bolus then 1.5 mg kg1 h1 as
an infusion. Our higher doses might have resulted in the
MAC-reducing effect of systemic lidocaine. Unfortunately we
did not measure the plasma levels of lidocaine (not available
in our hospital) but deﬁnitely they were higher than those lev-
els attained in their study (2 mcg ml1). Future studies are
needed to compare the MAC-reducing effect of lidocaine when
infused in different doses and exactly determine the required
plasma levels which can produce that effect.
The second difference is the design of the two studies. They
divided their study patients into 3 groups: general-epidural
group who received lidocaine in their epidurals, general anes-
thesia group who received systemic lidocaine and control gen-
eral anesthesia group. We divided our study patients into 2
groups only. Moreover, they changed the concentrations of
sevoﬂurane according to recorded BIS values above or below
50. When we examined their results we found some patients
who attained very low BIS (<30) and others with very high
values (>70). We manipulated sevoﬂurane concentrations to
strictly keep BIS values in our patients between 40 and 60.
Blinding was not complete in their study (epidural and general
anesthesia group) and randomization was not perfect either
because they directly assigned epidural-general patients to re-
ceive intravenous saline. On the contrary our study was fully
randomized and double blinded. The doses of intraoperative
opioids used in their study were not measured while in our
study they were not signiﬁcantly different between the 2 study
groups. There might have been differences in their opioid doses
that cause confounding in interpreting the results. Lastly our
study may be more powerful than theirs. We calculated our
power analysis with 0.01 alpha error and 0.1 beta error. Unfor-
tunately they did not mention the values they used in their
power analysis.
The dose of bolus and the rate of infusion of lidocaine used
in this study were based on previous studies that proved that
this dose did not result in plasma concentration more than
4 mcg ml1 [20–22], which is below the toxic levels [23].Since sevoﬂurane concentration was adjusted according to
BIS values, there was no difference between the 2 groups as
regard to BIS scores. However, no patient in the study could
recall intraoperative events. There was also no difference be-
tween the 2 groups as regard to fentanyl consumption. Extuba-
tion time was longer in the lidocaine group which can be
explained by blunting of the cough reﬂex by lidocaine [24].
In conclusion, intravenous lidocaine administration, during
maintenance of general anesthesia, can decrease BIS-guided
sevoﬂurane requirements.References
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